Last updated
WILDE: Capital Raising
Lexington, Kentucky protein snack maker WILDE secured a $40M investment from S2G Investments to expand manufacturing, develop new products and grow its national retail presence.
Source: Just Food
- What happened
- Lexington, Kentucky protein snack maker WILDE secured a $40M investment from S2G Investments to expand manufacturing, develop new products and grow its national retail presence.
- Who
- WILDE · USA
- When
- 2026-10-22
- Source
- Just Food
- So what
- Fresh capital is a hiring signal before it is anything else.
The leadership read
Fresh capital is a hiring signal before it is anything else. For WILDE, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where WILDE hires first across Americas; that is where the capital is really pointed.
Market context: The wider read — a Talent Market Index of 122.7 (Hot), up 17.8 month-on-month — shows Americas signal flow rising (+34.4pts).
WILDE: 1 signal in the last 90 days.
MitchelLake in this thematic
More signals across Americas
Capital Raising · Americas
NEXT Properties →NEXT Properties announced expiration results of exchange offers for its 6.950% Senior Notes due 2044 and 6.390% Senior Notes due 2050, exchanged for new 7.731% Senior Sustainability-Linked Notes due 2056.
Capital Raising · Americas
Janus Electric Holdings Limited →Janus Electric (ASX: JNS) secured A$11m in financing from CBA, comprising a A$10m revolving trade finance facility and a A$1m asset finance facility, to fund working capital and production capacity for its North American order book (118 trucks) and initial US truck conversion dispatches.
Capital Raising · Americas
3Srobotics →Chinese intelligent welding robotics company completed three funding rounds in under a year, with the latest raising tens of millions of USD, and is making its North American debut at FABTECH US 2026 in Las Vegas.
Capital Raising · Americas
Xona Space Systems →Xona (Korean outlet: 조나) closed a $250M Series D equity round led by Future Ventures at a $2.45B valuation, bringing total funding past $570M. The company is moving from validation to early commercial deployment of its Pulsar LEO navigation network.
Capital Raising · Americas
Familiar Therapeutics →Redwood City-based Familiar Therapeutics raised $5M in seed funding to develop FDA-approved human medicines repurposed for dogs and cats, led by Pioneer Fund, Icehouse Ventures and BreakTHRU.
Capital Raising · Americas
Star Therapeutics →Star Therapeutics secured $200M in private financing co-led by OrbiMed and Janus Henderson Investors, following Incyte's up-to-$2B acquisition of its subsidiary Vega Therapeutics in July 2026.
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record